Original article
Overrepresentation of 1q21–23 and 12q13–21 in lipoma-like liposarcomas but not in benign lipomas: A comparative genomic hybridization study

https://doi.org/10.1016/S0165-4608(96)00436-0Get rights and content

Abstract

Twenty lipomatous tumors, including eight lipoma-like liposarcomas and 12 benign lipomas, were analyzed using comparative genomic hybridization (CGH). DNA sequence copy number changes detected in five lipoma-like liposarcomas (mean, 1.1 aberrations/tumor; range, 0–2) consisted of gains of 12q13–21 (five tumors) and 1q21–23 (four tumors). Two of the tumors showed high-level amplification at 12q14–21 and one tumor at 1q21–22. No copy number changes were found in lipomas. Overrepresentation of 1q and 12q sequences was a recurrent finding in lipoma-like liposarcomas but not in lipomas. Thus, CGH may help in the differential diagnosis of low-grade or borderline adipose neoplasms.

References (33)

  • C. Sreekantaiah et al.

    Cytogenetic profile of 109 lipomas

    Cancer Res

    (1991)
  • N. Mandahl et al.

    Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors

    Genes Chromosom Cancer

    (1994)
  • A.A. Sandberg et al.

    The Cytogenetics of Bone and Soft Tissue Tumors

    (1994)
  • R.F. Suijkerbuijk et al.

    Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas

    Genes Chromosom Cancer

    (1994)
  • A. Forus et al.

    Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas

    Genes Chromosom Cancer

    (1995)
  • A. Forus et al.

    Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas

    Genes Chromosom Cancer

    (1995)

    • Cited by (60)

    • Molecular cytogenetic anomalies and phenotype alterations in a newly established cell line from Wilms tumor with diffuse anaplasia

      2008, Cancer Genetics and Cytogenetics
      Citation Excerpt :

      Candidate genes located at 1q21∼q22 that could be involved in Wilms tumor pathogenesis include the CKS1B, PSMD4, MUC1, TGFB2, IL6R, MCL1, TPM3 (alias TRK), and SKI genes. The regulatory sequences of an unknown putative target gene for Wilms tumor were recently mapped to 1q21∼q22 [26]; however, gain of 1q21∼q22 sequences has also been observed in leiomyosarcomas [27], lipoma-like liposarcomas [28], osteosarcomas [29], and multiple myeloma [30]. The second region with significant copy number gain detected by CGH in WT-Pe.1 cells covers the entire 4 p arm.

    • Sarcoma

      2007, Mayo Clinic Proceedings
      Citation Excerpt :

      A prognostic nomogram specific for liposarcomas has recently been described that may facilitate stratification for clinical trials and aid in the counseling of patients.145 Although the etiology of liposarcoma is unknown, a variety of cytogenetic abnormalities have been described, and gain of 1q and 12q sequences is commonly observed.146,147 The PPAR and CEBP families of transcription factors play important roles in adipocyte differentiation.148,149

    • Multi-Layer Micro-Nanofluidic Device for Isolation and Capture of Extracellular Vesicles Derived from Liposarcoma Cell Conditioned Media

      2020, Journal of Microelectromechanical Systems

    • Liposarcoma: molecular targets and therapeutic implications

      2016, Cellular and Molecular Life Sciences

    • Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma

      2015, Cell Death and Differentiation

    • The clinical utility of conventional karyotyping in the detection of cytogenetic abnormalities in soft tissue tumours: An asian institutional experience

      2014, Hong Kong Medical Journal
    View all citing articles on Scopus
    View full text
    Copyright © 1997 Published by Elsevier Inc.